<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR630.html">Part 630
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 630.6  Donor notification.
                            </h3>
                            <p class="depth0"><em>(a)</em> Notification of donors. You, an establishment that collects blood or blood components, must make reasonable attempts to notify any donor, including an autologous donor, who has been deferred based on the results of tests for evidence of infection with a communicable disease agent(s) as required by Sec. 610.41 of this chapter; or who has been determined not to be suitable as a donor based on suitability criteria under Sec. 640.3 or Sec. 640.63 of this

chapter. You must attempt to obtain the results of supplemental testing required under Sec. 610.40(e) of this chapter prior to notifying a donor of the deferral. If notification occurs prior to receipt of such results, you must also notify a deferred donor of the results of the supplemental testing. You must notify a donor as described in paragraph (b) of this section.</p><p class="depth0"><em>(b)</em> Content of notification. You must provide the following information to a donor deferred or determined not to be suitable as a donor as described in paragraph (a) of this section:</p><p class="depth0"><em>(1)</em> That the donor is deferred or determined not to be suitable for donation and the reason for that decision;</p><p class="depth0"><em>(2)</em> Where appropriate, the types of donation of blood or blood components that the donor should not donate in the future;</p><p class="depth0"><em>(3)</em> Where applicable, the results of tests for evidence of infection due to communicable disease agent(s) that were a basis for deferral under Sec. 610.41 of this chapter, including results of supplemental (i.e., additional, more specific) tests as required in Sec. 610.40(e) of this chapter; and,</p><p class="depth0"><em>(4)</em> Where appropriate, information concerning medical followup and counseling.</p><p class="depth0"><em>(c)</em> Time period for notification. You must make reasonable attempts to notify the donor within 8 weeks after determining that the donor is deferred or determined not to be suitable for donation as described in paragraph (a) of this section. You must document that you have successfully notified the donor or when you are unsuccessful that you have made reasonable attempts to notify the donor.</p><p class="depth0"><em>(d)</em> Autologous donors. (1) You also must provide the following information to the referring physician of an autologous donor who is deferred based on the results of tests for evidence of infection with a communicable disease agent(s) as described in paragraph (a) of this section:</p><p class="depth0"><em>(i)</em> Information that the autologous donor is deferred based on the results of tests for evidence of infection due to communicable disease agent(s), as required under Sec. 610.41 of this chapter, and the reason for that decision;</p><p class="depth0"><em>(ii)</em> Where appropriate, the types of donation of blood or blood components that the autologous donor should not donate in the future; and</p><p class="depth0"><em>(iii)</em> The results of tests for evidence of infection due to communicable disease agent(s), that were a basis for deferral under Sec. 610.41 of this chapter, including results of supplemental (i.e., additional, more specific) tests as required in Sec. 610.40(e) of this chapter.</p><p class="depth0"><em>(2)</em> You must make reasonable attempts to notify the autologous donor's referring physician within 8 weeks after determining that the autologous donor is deferred as described in paragraph (a) of this section. You must document that you have successfully notified the autologous donor's referring physician or when you are unsuccessful that you have made reasonable attempts to notify the physician.</p><p class="depth0">Effective Date Notes: 1. At 80 FR 29898, May 22, 2015, Sec. 630.6 was redesignated as Sec. 630.40 and newly designated Sec. 630.40 was further redesignated to subpart C, effective May 23, 2016.</p><p class="depth0">2. At 80 FR 29898, May 22, 2015, newly designated Sec. 630.40 was amended as follows, effective May 23, 2016:</p><p class="depth0">a. Revise the section heading;</p><p class="depth0">b. In paragraph (a), revise the first sentence; and remove the word ``supplemental'' from the second and third sentences and add in its place ``further'';</p><p class="depth0">c. In paragraphs (b) introductory text and (b)(1), remove ``suitable'' and add in its place ``eligible'';</p><p class="depth0">d. In paragraph (b)(3), remove ``communicable disease agent(s)'' and add in its place ``relevant transfusion-transmitted infection(s)''; and remove ``supplemental (i.e., additional, more specific) tests'' and add in its place ``further testing'';</p><p class="depth0">e. In paragraph (c), remove ``suitable'' and add in its place ``eligible'';</p><p class="depth0">f. In paragraph (d)(1) introductory text, remove ``communicable disease agent(s)'' and add in its place ``relevant transfusion-transmitted infection(s) or whose platelets indicate evidence of a bacterial infection that is endogenous to the bloodstream of the donor'';</p><p class="depth0">g. In paragraph (d)(1)(i), remove ``communicable disease agent(s)'' and add in its place ``relevant transfusion-transmitted infection(s)''; and</p><p class="depth0">h. In paragraph (d)(1)(iii), remove ``communicable disease agent(s)'' and add in its place ``relevant transfusion-transmitted infection(s)''; and remove ``supplemental (i.e.,

additional, more specific) tests'' and add in its place ``further testing''.</p><p class="depth0">For the convenience of the user, the added and revised text is set forth as follows:</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
